131 related articles for article (PubMed ID: 37248422)
1. Synthesis and Biological Evaluation of a Library of Sulfonamide Analogs of Memantine to Target Glioblastoma.
Philo JE; Caudle JD; Moussa RN; Kampmeyer PM; Hasin TR; Seo DK; Sheaff RJ; Lamar AA
ChemMedChem; 2023 Aug; 18(16):e202300134. PubMed ID: 37248422
[TBL] [Abstract][Full Text] [Related]
2. Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma.
Cacciatore I; Fornasari E; Marinelli L; Eusepi P; Ciulla M; Ozdemir O; Tatar A; Turkez H; Di Stefano A
Eur J Pharm Sci; 2017 Nov; 109():402-411. PubMed ID: 28860082
[TBL] [Abstract][Full Text] [Related]
3. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
4. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
Albayrak G; Konac E; Dere UA; Emmez H
Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
[TBL] [Abstract][Full Text] [Related]
5. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
Altinoz MA; Elmaci İ
Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of
Hopkins MD; Witt RC; Flusche AME; Philo JE; Ozmer GL; Purser GH; Sheaff RJ; Lamar AA
Org Biomol Chem; 2022 Aug; 20(33):6680-6693. PubMed ID: 35950721
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel (S)-tryptamine derivatives containing an allyl group and an aryl sulfonamide unit as anticancer agents.
Guo Z; Xu Y; Peng Y; Haroon Ur Rashid ; Quan W; Xie P; Wu L; Jiang J; Wang L; Liu X
Bioorg Med Chem Lett; 2019 May; 29(9):1133-1137. PubMed ID: 30842032
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Structure-Activity Relationship Studies of Novel Aryl Sulfonamides and Their Activity against Human Breast Cancer Cell Lines.
Azevedo-Barbosa H; Ferreira-Silva GÁ; do Vale BP; Hawkes JA; Ionta M; Carvalho DT
Chem Biodivers; 2022 Dec; 19(12):e202200831. PubMed ID: 36305872
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
[TBL] [Abstract][Full Text] [Related]
10. Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.
Zeniou M; Fève M; Mameri S; Dong J; Salomé C; Chen W; El-Habr EA; Bousson F; Sy M; Obszynski J; Boh A; Villa P; Assad Kahn S; Didier B; Bagnard D; Junier MP; Chneiweiss H; Haiech J; Hibert M; Kilhoffer MC
PLoS One; 2015; 10(8):e0134793. PubMed ID: 26270679
[TBL] [Abstract][Full Text] [Related]
11. Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma.
Svec RL; Furiassi L; Skibinski CG; Fan TM; Riggins GJ; Hergenrother PJ
ACS Chem Biol; 2018 Nov; 13(11):3206-3216. PubMed ID: 30296373
[TBL] [Abstract][Full Text] [Related]
12. Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
Kang S; Lee JM; Jeon B; Elkamhawy A; Paik S; Hong J; Oh SJ; Paek SH; Lee CJ; Hassan AHE; Kang SS; Roh EJ
Eur J Med Chem; 2018 May; 151():186-198. PubMed ID: 29614416
[TBL] [Abstract][Full Text] [Related]
13. Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior.
Miranda A; Cova T; Sousa J; Vitorino C; Pais A
Future Med Chem; 2018 Jan; 10(1):121-131. PubMed ID: 29235374
[TBL] [Abstract][Full Text] [Related]
14. An Update on Synthesis of Coumarin Sulfonamides as Enzyme Inhibitors and Anticancer Agents.
Rubab L; Afroz S; Ahmad S; Hussain S; Nawaz I; Irfan A; Batool F; Kotwica-Mojzych K; Mojzych M
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268704
[TBL] [Abstract][Full Text] [Related]
15. Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells.
Poole AT; Sitko CA; Le C; Naus CC; Hill BM; Bushnell EAC; Chen VC
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):672-681. PubMed ID: 32156166
[TBL] [Abstract][Full Text] [Related]
16. Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides.
Yuan P; Gu X; Ni X; Qi Y; Shao X; Xu X; Liu J; Qian X
Bioorg Med Chem Lett; 2021 Nov; 51():128371. PubMed ID: 34534673
[TBL] [Abstract][Full Text] [Related]
17. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
Kumar H; Sharma B
Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
19. Aromatic sulfonamides containing a condensed piperidine moiety as potential oxidative stress-inducing anticancer agents.
Madácsi R; Kanizsai I; Fehér LZ; Gyuris M; Ozsvári B; Erdélyi A; Wölfling J; Puskás LG
Med Chem; 2013 Nov; 9(7):911-9. PubMed ID: 23270324
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and antitumor screening of certain novel tetrahydroquinoline sulfonamides.
Alafeefy AM
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):189-94. PubMed ID: 24666309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
